XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net loss $ (19,594) $ (38,236) $ (121,994) $ (164,272)
Net loss before tax (17,757) (37,428) (118,805) (160,195)
Loss from operations (25,545) (39,403) (123,703) (172,352)
Operating Expenses, Total 609,474 533,988 1,770,632 1,605,108
Research and development 117,290 101,487 331,501 333,501
Sales and marketing 250,228 220,264 761,656 649,596
General and administrative 241,413 193,539 670,681 590,715
Impairment of long-lived and indefinite-lived assets 543 18,698 6,794 31,296
Gross Profit, Total 583,929 491,485 1,646,929 1,426,124
Revenue 850,739 708,655 2,368,609 2,045,443
Cost of sales 266,810 217,170 721,680 619,319
Other operating income 0 3,100 0 6,632
Total other income 7,788 1,975 4,898 12,157
Investment income, net 17,577 11,582 34,500 29,596
Interest expense, net (9,789) (9,607) (29,602) (17,439)
Income tax expense $ (1,837) $ (808) $ (3,189) $ (4,077)
Increase (decrease) in net loss per share (in usd per share) $ (0.10) $ (0.21) $ (0.65) $ (0.89)
Net loss per share—basic (in usd per share) $ (0.10) $ (0.21) $ (0.65) $ (0.89)
Weighted average common shares outstanding—diluted (in shares) 189,262 184,795 188,335 183,823
Weighted average common shares outstanding—basic (in shares) 189,262 184,795 188,335 183,823